<p>With April being Esophageal Cancer Awareness month, today's episode delves into the misconceptions and harmful effects of heartburn, the myths surrounding reflux surgery, and the future of heartburn therapy. Dr. Dan Lister, past-president of the American Foregut Society, provides insights on the risks associated with heartburn and the potential of precision medicine in addressing esophageal adenocarcinoma.</p><p></p><p>This episode was brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett's esophagus.</p><p></p>